 Checkpoint Therapeutics NASDAQ:CKPTs stock had its buy rating reissued by equities researchers at HC Wainwright in a report issued on Thursday, TipRanks reports. They currently have a 15.00 price objective on the stock. Separately, LADENBURG THALMSH SH restated a buy rating and set a 20.00 price target on shares of Checkpoint Therapeutics in a research ... 